Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma

MLA

Jérôme Fayette, et al. Efficacy and Safety of Capecitabine in Heavily Pretreated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Jan. 2012. EBSCOhost, https://doi.org/10.1097/CAD.0b013e328358d226⟩.

APA

Jérôme Fayette, Philippe Ceruse, Julien Péron, Antoine Ramade, Marc Poupart, Philippe Zrounba, & D. Girodet. (2012). Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma. https://doi.org/10.1097/CAD.0b013e328358d226⟩

Chicago

Jérôme Fayette, Philippe Ceruse, Julien Péron, Antoine Ramade, Marc Poupart, Philippe Zrounba, and D. Girodet. 2012. “Efficacy and Safety of Capecitabine in Heavily Pretreated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma,” January. doi:10.1097/CAD.0b013e328358d226⟩.